Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. by Lillioja, Stephen et al.
University of Wollongong 
Research Online 
Graduate School of Medicine - Papers (Archive) Faculty of Science, Medicine and Health 
1-1-1987 
Skeletal muscle capillary density and fiber type are possible determinants 
of in vivo insulin resistance in man. 
Stephen Lillioja 
University of Wollongong, lillioja@uow.edu.au 
A Young 
National Institutes of Health, Arizona 
Carol L. Culter 
University of Texas 
John L. Ivy 
University of Texas 
W Abbott 
National Institutes of Health, Phoenix 
See next page for additional authors 
Follow this and additional works at: https://ro.uow.edu.au/medpapers 
 Part of the Medicine and Health Sciences Commons 
Citation 
Lillioja, Stephen; Young, A; Culter, Carol L.; Ivy, John L.; Abbott, W; Zawadzki, J K.; Yki-Jarvinen, H; Christin, 
L; Secomb, Timothy W.; and Bogardus, Clitton, 1987, Skeletal muscle capillary density and fiber type are 
possible determinants of in vivo insulin resistance in man., 415-424. 
https://ro.uow.edu.au/medpapers/621 
Research Online is the open access institutional repository for the University of Wollongong. For further information 
contact the UOW Library: research-pubs@uow.edu.au 
Skeletal muscle capillary density and fiber type are possible determinants of in 
vivo insulin resistance in man. 
Abstract 
We have compared the capillary density and muscle fiber type of musculus vastus lateralis with in vivo 
insulin action determined by the euglycemic clamp (M value) in 23 Caucasians and 41 Pima Indian 
nondiabetic men. M value was significantly correlated with capillary density (r = 0.63; P less than or equal 
to 0.0001), percent type I fibers (r = 0.29; P less than 0.02), and percent type 2B fibers (r = -0.38; P less 
than 0.003). Fasting plasma glucose and insulin concentrations were significantly negatively correlated 
with capillary density (r = -0.46, P less than or equal to 0.0001; r = -0.47, P less than or equal to 0.0001, 
respectively). Waist circumference/thigh circumference ratio was correlated with percent type 1 fibers (r = 
-0.39; P less than 0.002). These results suggest that diffusion distance from capillary to muscle cells or 
some associated biochemical change, and fiber type, could play a role in determining in vivo insulin 
action. The association of muscle fiber type with body fat distribution may indicate that central obesity is 
only one aspect of a more generalized metabolic syndrome. The data may provide at least a partial 
explanation for the insulin resistance associated with obesity and for the altered kinetics of insulin action 
in the obese. 
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Abstract
We have compared the capillary density and muscle fiber type
of musculus vastus lateralis with in vivo insulin action determined
by the euglycemic clamp (M value) in 23 Caucasians and 41
Pima Indian nondiabetic men. M value was significantly corre-
lated with capillary density (r = 0.63; P < 0.0001), percent type
I fibers (r = 0.29; P < 0.02), and percent type 2B fibers (r
= -0.38; P < 0.003). Fasting plasma glucose and insulin con-
centrations were significantly negatively correlated with capillary
density (r = -0.46, P . 0.0001; r = -0.47, P . 0.0001, re-
spectively). Waist circumference/thigh circumference ratio was
correlated with percent type 1 fibers (r = -039; P < 0.002).
These results suggest that diffusion distance from capillary to
muscle cells or some associated biochemical change, and fiber
type, could play a role in determining in vivo insulin action. The
association of muscle fiber type with body fat distribution may
indicate that central obesity is only one aspect of a more gen-
eralized metabolic syndrome. The data may provide at least a
partial explanation for the insulin resistance associated with
obesity and for the altered kinetics of insulin action in the obese.
Introduction
There is a wide range of insulin action in subjects with normal
glucose tolerance (1), and furthermore the degree ofimpairment
ofinsulin action in the most insulin-resistant nondiabetic subjects
is as severe as that in overtly diabetic subjects (2, 3). Recent
evidence suggests that much of an oral or intravenous glucose
load is disposed of in skeletal muscle and stored (4, 5), and
skeletal muscle therefore is likely to be the site of this in vivo
insulin resistance. To date no definite explanation for the as-
sociation of in vivo insulin resistance and obesity has become
available. Nevertheless it is clear that insulin action in muscle
could be determined by defects at a whole series of steps from
the insulin receptor onwards. Lingarde et al. and Lithell et al.
have provided evidence that morphological changes in muscle,
particularly the size of muscle cells and the capillary supply to
muscle, are associated with changes in fasting insulin concen-
trations and glucose tolerance (6, 7). This has raised the possibility
that in addition to cellular biochemical defects the arrangement
of capillaries and muscle fibers could also influence insulin ac-
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tion. We now provide direct measurements of insulin action
using the euglycemic clamp method and muscle morphology.
In the current study we have compared in vivo insulin action
with skeletal muscle morphology in 23 Caucasian and 41 Pima
Indian men to test the hypothesis that impaired insulin action
may be related to alterations in skeletal muscle function that
are associated with altered skeletal muscle morphology.
Methods
Study subjects. The current studies were conducted in the Clinical Di-
abetes and Nutrition Section ofthe National Institute ofDiabetes, Diges-
tive and Kidney Diseases, National Institutes of Health, Phoenix, AZ.
All subjects were in good health as assessed with a medical history, physical
examination, and routine hematological, chemical, and urine tests. No
subjects had diabetes mellitus and only one subject, a Caucasian, had
impaired glucose tolerance (8) (fasting glucose, 98 mg/dl; 1 h glucose,
207 mg/dl; 2 h glucose, 140 mg/dl). All subjects gave written informed
consent, and the studies were approved by the ethics committees of the
National Institutes of Health and the Indian Health Service, and by the
Gila River Indian Community. Clinical data for the subjects were shown
in Table I. Subjects were fed a weight maintenance diet (50% carbohy-
drate, 30% fat, and 20% protein). Caloric requirements were predicted
from body weight or fat-free mass after it was measured. Calories in the
diet were adjusted according to fasting nude weight measured each
morning. Body composition was determined by underwater weighing
(9) with simultaneous determination of residual lung volume. Percent
fat, calculated according to Keys and Brozek (10), was used to calculate
fat-free mass (FFM).' Glucose uptake and maximal oxygen uptake rates
were divided by FFM to adjust for variations in metabolic body size
among individuals.
Experimental protocol. Each subject stayed on the research unit for
8-15 d. On the fourth or subsequent day of their stay an oral glucose
tolerance test was performed (8). On the seventh or subsequent day a
euglycemic clamp was performed. An assessment of maximum oxygen
uptake (VO2 max) was performed on the last day of the hospital stay.
During the hospital stay a biopsy was obtained from musculus vastus
lateralis. Fasting glucoses are the means of values obtained in duplicate
on three mornings. Fasting insulins are means of samples obtained at
the same time as the glucoses plus duplicate samples collected before
the euglycemic clamp.
Muscle biopsy. A biopsy of musculus vastus lateralis was obtained
via an 8-mm incision through skin and fascia 1-2 inches from the midline
in the midlateral thigh using a Bergstrom needle. The patient was supine
with the lower limb slightly internally rotated, and the biopsy needle was
directed vertically. The specimen was examined under a low-powered
microscope to determine muscle fiber orientation. The specimen was
1. Abbreviations used in this paper: CV, coefficient of variation; EGPR,
endogenous glucose production rate; FFM, fat-free mass; max M, glucose
uptake at maximally stimulating insulin concentration; Ra, appearance
rate; submax M, glucose uptake at submaximally stimulating insulin
concentrations; V02 max, maximum oxygen uptake; W/T, waist cir-
cumference to thigh circumference ratio.
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Table I. Clinical Data
Minimum and
Mean±SD maximum value
Age (yr) 27±6 18-41
Weight (kg) 95.1±30.9 49.4-176.3
Height (m) 1.72±0.07 1.59-1.91
Waist/thigh 1.60±0.16 1.31-2.03
Body fat (%)* 25±10 5-48
Fasting glucose (mg/dl)t 96±7 82-116
2 h glucose (OGTT) (mg/dl) 119±23 75-178
Fasting insulin (uU/m)i' 28±5 9-69
2 h insulin (OGTT) (uU/ml) 154±184 19-1191
Submax M (mg/kg FFM. min) 4.29±2.13 1.77-9.99
Max M (mg/kg FFM min) 11.66±3.15 6.00-18.30
VO2max (ml/kg FFM- min)11 51.5±8.6 33.8-74.5
Fiber area (um2) 6146±1700 3587-10618
Capillaries/muscle fiber 1.60±0.30 0.87-2.30
No. capillaries around each fiber 4.3±0.7 2.4-6.2
Capillaries/mm2 275±64 161-426
%Type 1 46±11 23-74
% Type 2a 27±12 4-54
% Type 2b 27±15 0-61
Muscle fiber data refer to musculus vastus lateralis.
* From underwater weighing.
* Drawn in duplicate on three separate days.
* Drawn in duplicate on four separate days.
n= 56.
then mounted in an imbedding matrix (OCT compound, Miles Labo-
ratories, Naperville, IL) and frozen in isopentane (Aldrich Chemical Co.,
Milwaukee, WI) cooled to its freezing point with liquid N2. All muscle
analyses were performed at the University of Texas.
Euglycemic clamp (submax M, max M). The euglycemic clamp
was performed by a modification of the method of DeFronzo et al. (11)
after a 13-14-h overnight fast. At 0600 h, after voiding, an intravenous
catheter was placed in an antecubital vein for infusion of insulin, glucose,
and 3-[3H]glucose. Another catheter was placed retrograde in a dorsal
vein ofthe contralateral hand for blood withdrawal. The hand was kept
in a warming box at 70°C. A primed continuous infusion of 3-[3Hjglucose
was then begun and continued throughout the first insulin infusion period.
After 2 h of 3-[3H]glucose infusion, four plasma samples were obtained
during a 20-min period for 3-[3Hlglucose specific activity determinations.
At the end of this collection period a primed continuous infusion of
purified pork insulin (Velosulin; Nordisk USA, Bethesda, MD) (40 mU/
mI per min) (submax M) was started. 5 min after the start ofthe insulin,
a variable 20% glucose infusion was begun to maintain the plasma glucose
concentration at approximately the basal glucose level for the entire 100
min of hyperinsulinemia. Samples for plasma glucose concentration were
obtained every 5 min throughout the test. Samples for 3-[3H]glucose
specific activity were obtained every 10 min from 60 to 100 min. 100
min after the start ofthe first insulin infusion, a second primed continuous
infusion ofinsulin was commenced (400 mU/M2 per min) (max M) and
continued for a further 100 min. Samples were drawn for measurement
of insulin levels at 15 and 8 min before the start ofthe insulin infusion,
and at 85, 95, 185, and 195 min afterwards. Mean (±SE) ofglucose and
insulin levels during the clamp were: lower insulin infusion (submax
M), glucose 95±0.6 mg/100 ml (mean coefficient of variation [CV]
2.4±0.1%), insulin 119±4.7 MU/ml (mean CV 4.6±0.6%); higher insulin
(max M) infusion, glucose 95±0.5 mg/100 ml (mean CV 3.1±0.2%),
insulin 2,027±75 uU/ml (CV 7.2±1.9%).
The appearance rate (Ra) of glucose in the plasma was calculated
from the plasma 3-[3H]glucose specific activities using the equations of
Steel (12). During the euglycemic clamp the endogenous glucose pro-
duction rate (EGPR) equals the difference between exogenous glucose
infusion rate and Ra calculated using Steele's non-steady state equations
(EGPR = Ra - exogenous glucose infusion rate). When Ra equals ex-
ogenous glucose infusion rate, EGPR is assumed to be completely sup-
pressed so that the total glucose disposal rate equals the exogenous glucose
infusion rate. These data were calculated for each 20-min interval in the
60-100 min period of the euglycemic clamp and then averaged to cal-
culate the total glucose uptake. Data were similarly calculated from 160
to 200 min but without the tritiated glucose measurements. Insulin
clearance rates have been shown to vary among individuals (13, 14). In
this report those subjects with the lower glucose uptake rates had higher
insulin concentrations at each insulin infusion level.
V02 max determination. A graded exercise test was performed the
day after the euglycemic clamp procedure by using intermittent work
bouts on a treadmill (data available on 56 subjects only). Each test was
started at 0-5 degrees elevation and involved walking at 1.5 mph. Ele-
vation and speed of the treadmill were gradually increased. After 4 min
at each work level, the subject sat down until the heart rate was < 120
beats per minute (bpm), and he had subjectively recovered. The test
continued until the patient was subjectively exhausted, the heart rate
reached 200 bpm, or there was no further increase in oxygen uptake
(VO2) (see references 15, 16). V02 was determined during the last 30 s
to 1 min ofeach work bout. The subject was connected to a low-resistance
mouthpiece of a "J" value (Warren E. Collins, Inc., Braintree, MA).
After 0.5-1 min of adaptation the expired air was collected in a 120-
liter Tissot spirometer (Warren E. Collins, Inc.). During the collection
period a sample ofexpired air was continuously drawn and analyzed for
oxygen and carbon dioxide. The average fraction of02 and C02, minute
ventilation oxygen uptake, CO2 production, and respiratory quotient
were calculated by an on-line Hewlett Packard 85 computer and printed
out at the end ofeach collection. V02 max was determined as the highest
V02 value recorded during the exercise test.
Analytical methods. Plasma glucose concentration was measured by
the glucose oxidase method using a glucose analyzer (Beckman Instru-
ments, Inc., Fullerton, CA). Plasma insulin concentration was determined
by the Herbert modification (17) of the radioimmunoassay of Berson
and Yalow (18). The tritiated glucose specific activity in blood samples
was measured, as described previously by others (19), using perchloric
acid to precipitate plasma proteins.
Biopsy specimens were mounted in an imbedding matrix (OCT) and
frozen in isopentane cooled to its freezing point with liquid N2. Tissue
slices 12 um thick were cut in a cryosat set at -20'C and used for
histochemical analysis. Sections were fixed, treated with a 1% amylase
solution, and stained with periodic acid-Schiff reagent to visualize cap-
illaries (20). The stained sections were analyzed by magnifying (X 296)
and projecting numerous artifact-free 0.25 mm2 areas onto a screen (Fig.
1). The number of capillaries within the known area were counted and
capillary density (cap/mm2) determined. Fiber type analysis was also
performed. Sections were stained for their myosin ATP-ase activity ac-
cording to Padykula and Herman (24), after preincubation at pH 4.30,
4.54, and 9.60. The fibers were classified as either type I, Ila, or Ilb
according to Dubowitz and Brooke (25).
Figure 1. Cross-section of skeletal
muscle copied from projected im-
age of microscopic slide used in
sample analysis (see Methods). For
this subject, mean fiber area
= 4,250 um2, capillary density
= 399 caps/mm2, capillaries per fi-
ber = 1.68, and capillaries around
each fiber = 4.7. Capillaries and
muscle fibers run parallel to each
other, perpendicular to the page
(21-23).
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Statistical methods. All statistical calculations, including calculations
of means, correlations, multiple regression, and multivariate regression
(partial regression) analyses were performed using standard programs of
the SAS Institute (Statistical Analysis System, Cary, NC). Correlations
are Pearson-product moment correlations. Log transformations of fasting
insulin and fiber area were used to decrease unequal variances in the
regressions, and a log transformation ofsubmax M was used to improve
linearity and normalize the distribution.
Results
In vivo insulin action at submaximal and maximal stimulating
insulin infusion rates (submax M and max M) was significantly
correlated with the number ofcapillaries per unit area in skeletal
muscle cross-sections (caps/mm2; capillary density) (r = 0.63,
P < 0.0001; r = 0.47, P < 0.0001, respectively) (Fig. 2). Submax
M (Fig. 3) and max M (Fig. 4) were also correlated with skeletal
muscle fiber types (for percent type I fibers, r = 0.29, P < 0.02;
r = 0.29, P < 0.03, respectively; for percent type 2B fibers, r
= -0.38, P < 0.003; r = -0.32, P < 0.01, respectively). The
relationship between submax M and percent type 2B fibers was
significant, independent of capillary density (r = -0.28, P
< 0.03); the relationship of max M and percent type 2B was
weakly significant, independent of capillary density (r = -0.23,
P = 0.06). Both measures of insulin action were negatively cor-
related with degree of obesity (percent fat) and waist circumfer-
ence/thigh circumference ratio (W/T) (Table II). Fasting plasma
glucose (Fig. 5) and fasting plasma insulin (Fig. 6) concentrations
were negatively correlated with capillary density (r = -0.46, P
< 0.0001; r =-0.47, P < 0.0001).
Using multivariate regression submax M was correlated with
capillary density independent of percent fat or W/T (Tables III
and IV) (r = 0.36, P < 0.004; r = 0.37, P < 0.003, respectively).
Max M was correlated with capillary density independent of
percent fat (r = 0.27, P < 0.04) but not independent ofW/T (r
= 0.19, P = 0. 13). The relationships between insulin action and
fiber type were no longer significant when either percent fat or
W/T were taken into account. Percent fat and W/T remain sig-
nificantly correlated with insulin action independent of capillary
density (Table V) (r = -0.57, P < 0.0001; r = -0.50, Ps 0.0001
for submax M) (r = -0.29, P < 0.03; r = -0.42, P < 0.001 for
max M). Using multiple regression capillary density, percent fat,
or W/T alone explained 40, 53, and 48%, respectively, of the
variance ofsubmax M. Capillary density and percent fat together
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Figure 3. Correlation of submax M and percent type 2B fibers (r
=-0.38, P < 0.003). (x) Indians; (.) Caucasians.
the variance of submax M, respectively. Equivalent values for
max M were 22, 24, 33, 29, and 36%.
Capillary density was significantly lower in the most obese
(r = -0.59, P < 0.0001) (Fig. 7). This was partially explained
by the observations that while muscle fiber cross-sectional area
was greater in the most obese (r = 0.39, P < 0.002) (Fig. 8), the
number of capillaries for each muscle fiber was no greater (r
= -0.17, P = 0.2). However, the most obese had lower capillary
densities even when fiber area was taken into account (r = -0.48,
P . 0.0001) by multivariate regression.
Degree of obesity was significantly correlated with muscle
fiber types (r = -0.32, P < 0.01; r = 0.32, P < 0.02 for percent
type 1 and type 2B, respectively). W/T as a measure ofbody fat
distribution was even more closely related to capillary density
(Fig. 9), percent type 1 fibers (Fig. 10) and percent type 2B fibers
(r = -0.60, P < 0.0001; r = -0.39, P < 0.002; r = 0.40, P
< 0.002, respectively). The r2 ofthe relationship ofpercent type
1 fibers and percent type 2b fibers to percent fat was 0.10 and
0.10, respectively. The r2 for fiber types and W/T were 0.16 and
0.16, respectively. When both percent fat and W/T were used
as regressors in the same model the r2 values were 0.16 and 0.16
for percent type 1 and 2b fibers, i.e., any contribution percent
fat made to the fiber type variance could be known if the W/T
was known. The relationships ofcapillary density and fiber type
with W/T were still significant or almost so when the degree of
obesity was taken into account (Table III) (r = -0.29, P < 0.03;
r = -0.24, P = 0.06; r = 0.25, P < 0.05 for caps/mm2, percent
type 1, percent type 2B, respectively).
V02 max was correlated with capillary density (r = 0.32, P
< 0.02), percent type 1 fibers (r = 0.29, P < 0.05) and percent
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Figure 2. Relationship of glucose uptake at submaximal stimulating
insulin concentrations and capillary density. The relationship is non-
linear and therefore plotted on a log scale for M (r = 0.63, P
< 0.0001). (x) Indians; (.) Caucasians.
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Figure 4. Correlation of max M and percent type 1 fibers (r = 0.29, P
< 0.03). (x) Indians; (-) Caucasians.











Table II. Simple Correlations: Correlation Coefficients/P Values
Submax Fasting Fasting % Type Capillaries/ Capillaries/ % Body
M Max M glucose* insulint % Type 1 2B Fiber area fiber mm2 fat5
Max M 0.81
<0.0001
Fasting glucose* -0.51 -0.27
.0.0001 <0.04
Fasting insulint -0.78 -0.70 0.54
<0.0001 .0.0001 .0.0001
%Type 1 0.29 0.29 -0.11 K-0.23
<0.02 <0.03 =0.4 =0.06
%Type 2B -0.38 -0.32 0.24 0.31 -0.63
<0.003 <0.01 =0.05 <0.02 .0.0001
Fiber area -0.49 -0.37 0.39 0.42 -0.08 0.07
.0.0001 <0.003 <0.002 <0.0006 =0.5 =0.6
Capillaries/muscle fiber 0.07 0.03 -0.06 0.01 0.34 -0.23 0.53
=0.6 =0.8 =0.7 =0.9 <0.01 =0.07 .0.0001
Capillaries/mm2 0.63 0.47 -0.46 -0.47 0.39 -0.27 -0.68 0.24
.0.0001 .0.0001 <0.0001 .0.0001 <0.002 <0.04 .0.0001 =0.05
%Body fate -0.73 -0.49 0.48 0.70 -0.32 0.32 0.39 -0.17 -0.59
.0.0001 .0.0001 <0.0001 .0.0001 <0.01 <0.02 <0.002 =0.2 .0.0001
W/T -0.69 -0.58 0.47 0.71 -0.39 0.40 0.32 -0.29 -0.60 0.78
.0.0001 .0.0001 .0.0001 .0.0001 <0.002 <0.002 <0.01 <0.02 .0.0001 .0.0001
n = 64. Muscle fiber data refer to musculus vastus lateralis. * Drawn in duplicate on three separate days. t Drawn in duplicate on four separate
days. I From underwater weighing.
(r = 0.57, P . 0.0001 and r = 0.58, P . 0.0001 for submax and
max M, respectively).
Number of capillaries per muscle fiber and number of cap-
illaries per square millimeter (capillary density) (Fig. 1 1) both
correlated with percentage of type 1 fibers (r = 0.34, P < 0.01;
r = 0.39, P < 0.002, respectively). The correlations ofboth these
capillary measures with percent type 2B fibers was weaker (r
=-0.23, P = 0.07; r =-0.27, P < 0.04).
Discussion
muscle and the histologically determined proportions ofmuscle
fiber types. In addition, fasting plasma glucose concentrations
even within the narrow range of normal values were also strongly
correlated with capillary density. We also confirmed a previous
report that a central distribution of obesity is associated with a
higher proportion of type 2B fibers (26).
We propose that these data may be explained by some com-
binations of the following three mechanisms. Alterations in in-
sulin action may occur because (a) specific biochemical changes
We have demonstrated that in vivo insulin action is significantly
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Figure 5. Relationship of fasting glucose (mean of duplicates on three
different days) and capillary density (r = -0.46, P . 0.0001). (x) Indi-
ans; (e) Caucasians.
Figure 6. Relationship of fasting insulin (mean of duplicates on four
different days) and capillary density (r = -0.47, P . 0.0001). (x) Indi-
ans; (e) Caucasians.










Table III. Multivariate Regression: Independent Variable Percent Fat
Partial correlation coefficients/P values
Submax M Max M Fasting glucose* Fasting insulint % Type 1 % Type 2B CapiJlaries/mm2
Max M 0.76
<0.0001
Fasting glucose* -0.26 -0.04
<0.04 =0.7
Fasting insulint -0.55 -0.58 0.32
<0.0001 .0.0001 <0.02
% Type 1 0.09 0.16 0.05 0.0
=0.5 =0.21 =0.7 =0.9
% Type 2B -0.22 -0.21 0.10 0.13 -0.59
=0.08 =0.1 1 =0.5 =0.3 .0.0001
Capillaries/mm2 0.36 0.27 -0.25 -0.10 0.25 -0.10
<0.004 <0.04 =0.05 =0.4 <0.05 =0.4
W/T -0.29 -0.36 0.18 0.37 -0.24 0.25 -0.29
<0.03 <0.004 =0.16 <0.003 =0.06 <0.05 <0.03
Muscle fiber data refer to musculus vastus lateralis. * Drawn in duplicate on three separate days. * Drawn in duplicate on four separate days.
occur in association with variations in cellular oxidative capacity The data may also help provide mechanisms to explain the as-
(oxidative capacity being correlated with capillary supply), (b) sociation of obesity with insulin resistance and altered kinetics
limitations are imposed on the diffusion of insulin and perhaps ofinsulin action (37-40), to explain the association ofW/T with
glucose when capillaries are more widely spaced (c.f. 21), and disturbances of glucose tolerance (41), and to explain some of
(c) biochemical changes are induced in parallel with the specific the variation in fasting glucose concentrations within the normal
twitch characteristics (fiber type) ofmuscle fibers (see references range.
27-34). Furthermore, the correlation of fiber type with insulin Muscle analyses were performed on one small muscle sample
action may help explain the familial dependence ofinsulin action from only one skeletal muscle. Such sampling would be expected
because fiber type appears to be genetically determined (35, 36). to increase the scatter in the data when comparing the muscle
Table IV. Multivariate Regression: Independent Variable Waist/Thigh
Partial correlation coefficients/P values
Submax M Max M Fasting glucose* Fasting insulin$ % Type I % Type 2B Capillaries/mm2
MaxM 0.69
<0.0001
Fasting glucose* -0.29 0.0
<0.03 = 1.0
Fasting insulint -0.57 -0.51 0.32
.0.0001 .0.0001 <0.01
% Type 1 0.03 0.08 0.09 0.07
=0.8 =0.5 =0.5 =0.6
% Type 2B -0.15 -0.13 0.06 0.04 -0.56
=0.2 =0.3 =0.7 =0.7 .0.0001
Capillaries/mm2 0.37 0.19 -0.25 -0.08 0.20 -0.04
<0.003 =0.13 <0.05 =0.5 =0.11 =0.8
% Body fat0 -0.43 -0.07 0.21 0.34 -0.03 0.02 -0.24
<0.0006 =0.6 =0.10 <0.01 =0.8 =0.9 =0.06
Muscle fiber data refer to musculus vastus lateralis.
I Determined from underwater weighing.
* Drawn in duplicate on three separate days. t Drawn in duplicate on four separate days.
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Table V. Multivariate Regression: Independent Variable Capillaries/mm
Partial correlation coefficients/P values
Submax M Max M Fasting glucose Fasting insulin$ % Type I % Type 2B
Max M 0.74
.0.0001
Fasting glucose* -0.32 -0.06
<0.02 =0.6
Fasting insulint -0.71 -0.62 0.41
.0.0001 <0.0001 <0.001
% Type 1 0.07 0.13 0.08 -0.06
=0.6 =0.3 =0.5 =0.6
% Type 2B -0.28 -0.23 0.13 0.22 -0.60
<0.03 =0.06 =0.3 =0.09 .0.0001
% Body fat -0.57 -0.29 0.30 0.60 -0.13 0.21
.0.0001 <0.03 <0.02 .0.0001 =0.3 =0.10
W/T -0.50 -0.42 0.28 0.61 -0.22 0.31
.0.0001 <0.001 <0.03 .0.0001 =0.08 <0.02
Muscle fiber data refer to musculus vastus lateralis. * Drawn in duplicate on three separate days. t Drawn in duplicate on four separate days.
I Determined from underwater weighing.
observations with whole body observations. On the other hand
some studies have shown that the deeper portions of vastus la-
teralis have a greater proportion oftype 1 fibers than the surface
portions. Therefore, if by chance leaner subjects were biopsied
deeper than obese then the data might be biased. The observation
ofa variation in fiber type proportions throughout vastus lateralis
has not been consistently demonstrated however, so it is ques-
tionable how much this variation could have affected our data
(28, 42-44). Vastus intermedius may have more type 1 fibers
than vastus lateralis but an inadvertant biopsy of this muscle
would seem to be unlikely and rare. A relationship of fiber type
to obesity and insulin action should certainly be confirmed by
other human studies.
Capillary density and insulin action. Oxidative capacity of
skeletal muscle is associated with the presence ofa specific pattern
ofmuscle cell enzyme activities and an increased supply of cap-
illaries (27, 28, 33, 34, 45, 46). Hence correlations with capillary
density might reflect either correlations with cellular biochemical
changes or correlations directly related to the increased distance
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by each capillary. Tyrosine kinase activity of the insulin receptor
has been correlated with muscle fiber type (31). Because oxidative
capacity and capillary density are greater with type 1 fibers, it
is possible that the tyrosine kinase activity might correlate with
greater oxidative capacity of fibers, though this remains to be
directly tested. No studies have directly tested whether other
biochemical changes that influence insulin action are also as-
sociated with changes in oxidative capacity of muscle cells.
Removal of insulin or glucose from the plasma is regulated
by flow through the capillaries and the ability of the substance
to diffuse into the tissues (47, 48). James et al. (49) recently
showed that blood flow to skeletal muscle was not a determinant
ofglucose disposal indicating that diffusion was the limiting fac-
tor. Indeed, low extraction ratios are themselves an indication
that diffusion and not blood flow is limiting tissue uptake of
substrate (47, 48). Studies during oral glucose loading in man
have shown modest arterio-venous differences for glucose and
insulin, indicating that diffusion from the capillaries may be
important (50). Under most physiological conditions the major
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Figure 7. Relationship of capillary density and deee of obesity (per-
cent fat) (r = -0.59, P . 0.0001). (x) Indians; (-) Caucasians.
Figure 8. Relationship of muscle fiber cross-sectional area and degree
of obesity (r = 0.39, P < 0.002). (x) Indians; (.) Caucasians.













































Figure 9. Relationship of capillary density and W/T (r = -0.60, P
< 0.0001). (x) Indians; (.) Caucasians.
cle cell membrane. To insulin however, the nonfenestrated (5 1)
capillaries ofskeletal muscle provide a significant diffusion barrier
(48, 52-55) inspite of active transport through the capillary wall
(56). Furthermore the space between muscle cells may be very
narrow (0.1 sm) (57) and could further reduce insulin's diffusion
to the parts ofthe cell membrane most distance to the capillary.2
If such diffusion barriers do exist then those subjects with the
largest tissue volume depending on each capillary may have the
lowest average interfiber insulin concentrations and the worst
insulin action. We suggest that the correlations ofinsulin action
with capillary density could reflect some such mechanism, but
confirmation of this will await more direct studies. The corre-
lation ofmax M with capillary density was weaker than submax
M and was in fact not present independent of W/T. We have
already noted that the correlation could be due to as yet unknown
biochemical changes associated with changes in oxidative ca-
pacity. Alternatively, it is possible that when insulin action is
maximal and glucose uptake potentially very rapid, the rate of
diffusion of glucose down the narrow intracellular cleft or even
across the unfenestrated capillary walls could have reduced glu-
cose uptake in those with low capillary density.
In the basal state the lymphatic insulin appears to be lower
than the arterial insulin concentration (52). Because lymphatics
do not drain deep between muscle fibers (22, 23, 58), it is possible
that with reduced capillary density there is even a further re-
duction in insulin at those portions of the muscle cell with least
access to a capillary. The correlations of fasting glucose and
insulin with capillary density suggest that some direct or indirect
factor associated with capillary density must be having an effect
on basal glucose homeostasis.
The relationship of insulin action and capillary density could
explain several interesting observations in the literature. Prager
et al. (39) noted that at low insulin infusion rates there was
delayed activation of glucose uptake in obese subjects and this
delay was eliminated at very high insulin concentrations. Doe-
dem et al. (40) noted both a defect in the rate of response to
insulin and the amplitude of response in the obese, and noted
that the defect in insulin action in the obese was greater during
changing insulin levels. These effects are predicted by the results
of our studies, because increased diffusion distances with de-
creased capillary density in obese subjects would require greater
2. The concept ofinsulin or glucose gradients is an extension ofcylindrical
geometry models for oxygen diffusion first suggested by Krogh (21). We
are indebted to Dr. T. W. Secomb, Department of Physiology, University
of Arizona, Tucson, for his advice about capillary biophysics.
Figure 10. Relationship of percent type 1 muscle fibers in musculus
vastus lateralis and W/T (r = -0.39, P < 0.002). (x) Indians; (-) Cau-
casians.
time for insulin concentrations to reach a new equilibrium
around the muscle cells. Time taken to diffuse increases with
the square of the diffusion distances (48).
Muscle fiber type and insulin action. Structural differences
between the light chains ofmyosin ATP-ase result in differences
in the contractile speed (twitch) of myofibrils and the histo-
chemical staining of the cells that contain them (28, 59). All
human muscles are of mixed fiber type (44) but there appears
to be real differences in the proportions of particular muscle
fibers between individuals (28, 44). While there is probably not
total agreement, it appears that the proportions oftype 1 muscle
fibers may be genetically determined and relatively fixed, but
that interchange may occur between the subtypes 2A and 2B
(28, 33-35). In in vivo animal studies, slow twitch and fast twitch
oxidative fibers (types 1 and 2a) (27) have the greatest insulin
sensitivity and probably responsiveness, and fast twitch glycolytic
fibers (type 2B) have the least (29, 30, 32). However, it is not
yet known with certainty what determines the insulin sensitivity
of a particular fiber type. We have found a positive correlation
between insulin action and the percentage of type 1, and a neg-
ative correlation with the percentage of type 2B fibers in vastus
lateralis, as might have been predicted on the basis of animal
studies.
In vivo insulin action and skeletal muscle morphology: im-
plicationsfor the clinical correlates ofinsulin resistance. A genetic
component to insulin resistance is suggested by the recent ob-
servation that in vivo insulin action independent of degree of
obesity is a familial characteristic (36). The familial dependence
of insulin action is even stronger if obesity is not adjusted for
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Figure H1. Relationship of percent type I muscle fibers and capillary
density (r = 0.39, P < 0.002). (x) Indians; (.) Caucasians.




















that muscle fiber types are genetically determined. In light of
the current findings, it is therefore possible that the familial basis
of insulin action is due to inherited proportions of particular
fiber types. Insulin action and fiber types were not correlated
independently of percent fat. This might partially be explained
by the fact that it is more difficult to get a representative sample
ofmuscle than to measure obesity. The relationship of fiber type
and obesity could mean that insulin resistance from altered
muscle fiber type is linked in some way to the cause ofthe obesity
and that we cannot detect any additional relationship ofM value
and fiber type because of the lack of precision of our tests.
Obesity is associated with increases in FFM (61) and visceral
cell sizes (62). This increase in FFM is by definition independent
of any triglyceride accumulation in cells. Because muscle cells
do not multiply (63), their size must also increase with the in-
crease in FFM (6). We found that capillaries per muscle fiber,
however, did not increase with obesity and hence there was a
negative correlation of capillary density and percent fat. This
finding in obesity is not unlike what happens to the capillary
density in weight/power lifters (64). The relationship of capillary
density to obesity was, however, much stronger than that offiber
area to obesity so that factors in addition to muscle cell size may
be regulating the reduction in capillary density in the obese. The
regression analyses suggested that while obesity and capillary
density are related they both may have additional independent
effects on insulin action.
Fiber type was correlated with both percent fat and W/T.
The simple and multiple regression analyses showed that all of
the relationship between fiber type and obesity could be predicted
from W/T alone. It is possible, therefore, that the association of
fiber type and obesity is due to an association ofincreased central
adiposity and obesity. The relationship of fiber type and central
obesity, which others have also noted (26), might suggest that
fiber type and fat distribution are both parts ofa more generalized
syndrome producing insulin resistance and abnormal glucose
tolerance (41).
We noted a rise in glucose concentration over the range of
obesity consistent with the correlation of obesity and capillary
density, and capillary density and fasting glucose. While this
increase is small, the possibility should be considered that such
increases may initiate a vicious cycle of hyperglycemia, pan-
creatic refractoriness to glucose, and further hyperglycemia (65-
67). If such were the case, it might help to explain the effect of
duration of obesity on the incidence of diabetes (68).
In summary, we have found in vivo insulin action to be
significantly correlated with capillary density and the proportions
of muscle fiber types in musculus vastus lateralis. We postulate
that the association ofinsulin action and capillary density reflects
the effect of either some yet to be determined biochemical
changes (perhaps associated with alterations in muscle cell ox-
idative capacity) on insulin action or the effect of diffusion bar-
riers that limit the access ofinsulin and perhaps glucose to some
parts ofthe muscle cell wall. These diffusion effects are relatively
greater when capillary density is reduced, such as in obesity.
Therefore this data may provide a partial explanation of insulin
resistance in the obese. It may also provide an explanation for
slower response time ofinsulin action in obese subjects, because
increased diffusion distances imply a longer time for tissue insulin
and glucose concentrations to reach new steady states. The sig-
nificant association ofmuscle fiber type and insulin action could
be explained by biochemical differences in different types of
muscle fibers and/or associated effects of changes in capillary
density. The correlation ofW/T with fiber type may suggest that
a central distribution of obesity is part of a more generalized
syndrome. The association ofmuscle fiber type and insulin action
might explain the familial dependence of insulin resistance, be-
cause fiber type appears to be genetically determined.
Future work is needed to determine if human type 1, 2A,
and 2B muscle fiber differ in insulin sensitivity and responsive-
ness as they do in animals, and whether these are related to
muscle oxidative function or twitch characteristics. And finally,
more understanding is needed of the biophysical properties of
skeletal muscle that influence glucose and insulin diffusion.
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